Accepted Manuscript The N-terminal-truncated recombinant fibrin(ogen)olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre-clinical safety in rodent model Bandana Bora, Debananda Gogoi, Debabrata Tripathy, Sillarine Kurkalang, Sheetal Ramani, Anupam Chatterjee, Ashis K. Mukherjee PII: S0141-8130(17)34702-5 DOI: https://doi.org/10.1016/j.ijbiomac.2017.12.140 Reference: BIOMAC 8802 To appear in: Received date: 27 November 2017 Accepted date: 26 December 2017 Please cite this article as: Bandana Bora, Debananda Gogoi, Debabrata Tripathy, Sillarine Kurkalang, Sheetal Ramani, Anupam Chatterjee, Ashis K. Mukherjee , The N-terminal- truncated recombinant fibrin(ogen)olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre- clinical safety in rodent model. The address for the corresponding author was captured as affiliation for all authors. Please check if appropriate. Biomac(2017), https://doi.org/ 10.1016/j.ijbiomac.2017.12.140 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.